إعلان
إعلان
ATYR
aTyr Pharma, Inc. Common Stock
0.71
USDبرعاية
-0.01
-1.67%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
0.69
-0.02
-2.48%
تقارير أرباح ATYR
النسبة الإيجابية المفاجئة
ATYR تفوق 28 من 40 آخر التقديرات.
70%
التقرير التالي
بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$34.00K
/-$0.19
التغير الضمني من Q3 25 (Revenue/ EPS)
-82.11%
/-26.92%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+5.56%
aTyr Pharma, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, ATYR reported earnings of -0.26 USD per share (EPS) for Q3 25, missing the estimate of -0.18 USD, resulting in a -38.81% surprise. Revenue reached 190.00 ألف, compared to an expected 1.36 مليون, with a -86.03% difference. The market reacted with a +6.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 المحللين forecast an EPS of -0.19 USD, with revenue projected to reach 34.00 ألف USD, implying an نقصان of -26.92% EPS, and نقصان of -82.11% in Revenue from the last quarter.
الأسئلة الشائعة
What were aTyr Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, aTyr Pharma, Inc. Common Stock reported EPS of -$0.26, missing estimates by -38.81%, and revenue of $190.00K, -86.03% below expectations.
How did the market react to aTyr Pharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 6.05%, changed from $0.77 before the earnings release to $0.82 the day after.
When is aTyr Pharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
What are the forecasts for aTyr Pharma, Inc. Common Stock's next earnings report?
Based on 12
المحللين, aTyr Pharma, Inc. Common Stock is expected to report EPS of -$0.19 and revenue of $34.00K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان